Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Aug-24 4:30 PM View:  | Glycomimetics Inc (GLYC) | 08-Aug-24 | Sale | 260,873 | $0.19 | $50,009.40 | (4%) 6.58M to 6.32M | |
| 09-Aug-24 4:30 PM View: | Glycomimetics Inc (GLYC) | 07-Aug-24 | Sale | 61,488 | $0.18 | $11,197.00 | (< 1%) 6.64M to 6.58M | |
| 07-Aug-24 4:30 PM View: | Glycomimetics Inc (GLYC) | 06-Aug-24 | Sale | 55,732 | $0.18 | $10,187.80 | (< 1%) 6.7M to 6.64M | |
| 07-Aug-24 4:30 PM View: | Glycomimetics Inc (GLYC) | 05-Aug-24 | Sale | 164,523 | $0.19 | $30,996.10 | (2%) 6.86M to 6.7M | |
| 05-Aug-24 4:53 PM View: | Glycomimetics Inc (GLYC) | 02-Aug-24 | Sale | 286,200 | $0.20 | $57,354.50 | (4%) 7.15M to 6.86M | |
| 05-Aug-24 4:53 PM View: | Glycomimetics Inc (GLYC) | 01-Aug-24 | Sale | 63,564 | $0.22 | $13,742.50 | (< 1%) 7.21M to 7.15M | |
| 30-Jul-24 5:16 PM View: | Glycomimetics Inc (GLYC) | 30-Jul-24 | Sale | 756,835 | $0.22 | $167,185.00 | (9%) 7.97M to 7.21M | |
| 30-Jul-24 5:16 PM View: | Glycomimetics Inc (GLYC) | 29-Jul-24 | Sale | 363,949 | $0.24 | $85,637.20 | (4%) 8.33M to 7.97M | |
| 30-Jul-24 5:16 PM View: | Glycomimetics Inc (GLYC) | 26-Jul-24 | Sale | 258,335 | $0.24 | $62,439.60 | (3%) 8.59M to 8.33M | |
| 16-Oct-23 5:46 PM View: | Scholar Rock Holding Corp (SRRK) | 12-Oct-23 | Private Purchase | 2,199,930 | $6.86 | $15,086,700.00 | 24% 9.06M to 11.26M | |
| 02-May-23 10:00 PM View: | Scholar Rock Holding Corp (SRRK) | 28-Apr-23 | Private Purchase | 31,557 | $6.43 | $202,845.00 | < 1% 9.03M to 9.06M | |
| 28-Feb-23 10:00 PM View: | Glycomimetics Inc (GLYC) | 24-Feb-23 | Purchase | 100,000 | $1.70 | $170,000.00 | 1% 8.49M to 8.59M | |
| 23-Feb-23 6:23 PM View: | Glycomimetics Inc (GLYC) | 23-Feb-23 | Purchase | 200,000 | $1.75 | $350,760.00 | 2% 8.29M to 8.49M | |
| 23-Feb-23 6:23 PM View: | Glycomimetics Inc (GLYC) | 22-Feb-23 | Purchase | 150,000 | $1.79 | $268,995.00 | 2% 8.14M to 8.29M | |
| 23-Feb-23 6:23 PM View: | Glycomimetics Inc (GLYC) | 21-Feb-23 | Purchase | 50,000 | $1.85 | $92,500.00 | < 1% 8.09M to 8.14M | |
| 17-Feb-23 5:29 PM View: | Glycomimetics Inc (GLYC) | 17-Feb-23 | Purchase | 200,000 | $1.71 | $341,000.00 | 3% 7.89M to 8.09M | |
| 17-Feb-23 5:29 PM View: | Glycomimetics Inc (GLYC) | 16-Feb-23 | Purchase | 315,266 | $1.68 | $531,129.00 | 4% 7.57M to 7.89M | |
| 17-Feb-23 5:29 PM View: | Glycomimetics Inc (GLYC) | 15-Feb-23 | Purchase | 1,000,000 | $2.16 | $2,155,800.00 | 15% 6.57M to 7.57M | |
| 13-Feb-23 5:45 PM View: | Glycomimetics Inc (GLYC) | 09-Feb-23 | Purchase | 11,451 | $3.24 | $37,123.00 | < 1% 6.56M to 6.57M | |
| 11-Jan-23 8:30 PM View: | Scholar Rock Holding Corp (SRRK) | 09-Jan-23 | Sale | 1,094 | $9.48 | $10,373.30 | (< 1%) 9.03M to 9.03M | |
| 09-Jan-23 5:22 PM View: | Scholar Rock Holding Corp (SRRK) | 05-Jan-23 | Private Purchase | 48,774 | $9.33 | $455,091.00 | < 1% 8.98M to 9.03M | |
| 27-Oct-22 4:36 PM View: | Scholar Rock Holding Corp (SRRK) | 25-Oct-22 | Private Purchase | 130,265 | $8.04 | $1,047,380.00 | 1% 8.85M to 8.98M | |
| 07-Oct-22 4:30 PM View: | Scholar Rock Holding Corp (SRRK) | 04-Oct-22 | Purchase | 66,000 | $7.89 | $520,760.00 | < 1% 8.78M to 8.85M | |
| 07-Oct-22 4:30 PM View: | Scholar Rock Holding Corp (SRRK) | 03-Oct-22 | Private Purchase | 33,971 | $7.03 | $238,789.00 | < 1% 8.75M to 8.78M | |
| 03-Aug-21 5:16 PM View: | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Conversion | 1,323,530 | -- | -- | 1765% 75.0K to 1.4M | |
| 03-Aug-21 5:16 PM View: | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Market Purchase | 875,000 | $17.00 | $14,875,000.00 | 63% 1.4M to 2.27M | |
| 03-Aug-21 5:16 PM View: | Omega Therapeutics, Inc. (OMGA) | 30-Jul-21 | Purchase | 75,000 | $16.14 | $1,210,340.00 | 100% 0 to 75.0K | |
| 03-Feb-21 9:52 PM View: | Seer, Inc. (SEER) | 01-Feb-21 | Market Sale | 252,545 | $64.15 | $16,201,500.00 | (4%) 5.84M to 5.59M | 3% |
| 17-Dec-20 2:39 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 16-Dec-20 | Market Purchase | 10,937,500 | $3.20 | $35,000,000.00 | 18% 60.24M to 71.18M | 9% |
| 10-Dec-20 4:15 PM View: | Seer, Inc. (SEER) | 08-Dec-20 | Conversion | 5,050,910 | -- | -- | 100% 0 to 5.05M | |
| 10-Dec-20 4:15 PM View: | Seer, Inc. (SEER) | 08-Dec-20 | Purchase | 790,000 | $19.00 | $15,010,000.00 | 16% 5.05M to 5.84M | |
| 03-Nov-20 8:00 PM View: | Sqz Biotechnologies Co (SQZ) | 03-Nov-20 | Conversion | 1,141,310 | -- | -- | 100% 0 to 1.14M | |
| 03-Nov-20 8:00 PM View: | Sqz Biotechnologies Co (SQZ) | 03-Nov-20 | Purchase | 465,000 | $16.00 | $7,440,000.00 | 41% 1.14M to 1.61M | |
| 18-Jun-20 6:01 PM View: | Generation Bio Co. (GBIO) | 16-Jun-20 | Conversion | 2,014,190 | -- | -- | 100% 0 to 2.01M | |
| 18-Jun-20 6:01 PM View: | Generation Bio Co. (GBIO) | 16-Jun-20 | Purchase | 800,000 | $19.00 | $15,200,000.00 | 40% 2.01M to 2.81M | |
| 29-Jun-18 4:23 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Jun-18 | Market Purchase | 57,724 | $12.45 | $718,935.00 | < 1% 60.18M to 60.24M | (72%) |
| 29-Jun-18 4:23 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 27-Jun-18 | Market Purchase | 125,114 | $12.54 | $1,568,440.00 | < 1% 60.06M to 60.18M | (72%) |
| 26-Jun-18 5:32 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 25-Jun-18 | Market Purchase | 228,264 | $12.95 | $2,955,080.00 | < 1% 59.83M to 60.06M | (73%) |
| 26-Jun-18 5:32 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 22-Jun-18 | Market Purchase | 25,461 | $13.36 | $340,090.00 | < 1% 59.8M to 59.83M | (74%) |
| 21-Jun-18 5:55 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 21-Jun-18 | Market Purchase | 51,600 | $13.27 | $684,613.00 | < 1% 59.75M to 59.8M | (74%) |
| 21-Jun-18 5:55 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 20-Jun-18 | Market Purchase | 12,391 | $13.28 | $164,613.00 | < 1% 59.74M to 59.75M | (74%) |
| 21-Jun-18 5:55 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 19-Jun-18 | Market Purchase | 8,982 | $13.45 | $120,819.00 | < 1% 59.73M to 59.74M | (74%) |
| 18-Jun-18 6:56 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 18-Jun-18 | Market Purchase | 36,584 | $13.06 | $477,937.00 | < 1% 59.69M to 59.73M | (73%) |
| 18-Jun-18 6:56 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 14-Jun-18 | Market Purchase | 9,200 | $12.66 | $116,462.00 | < 1% 59.69M to 59.69M | (72%) |
| 12-Jun-18 6:10 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 12-Jun-18 | Market Purchase | 107,023 | $12.83 | $1,373,240.00 | < 1% 59.58M to 59.69M | (73%) |
| 12-Jun-18 6:10 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 11-Jun-18 | Market Purchase | 98,626 | $12.75 | $1,257,450.00 | < 1% 59.48M to 59.58M | (73%) |
| 12-Jun-18 6:10 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 08-Jun-18 | Market Purchase | 29,747 | $12.89 | $383,427.00 | < 1% 59.45M to 59.48M | (73%) |
| 07-Jun-18 7:37 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 07-Jun-18 | Market Purchase | 57,439 | $12.93 | $742,508.00 | < 1% 59.39M to 59.45M | (73%) |
| 07-Jun-18 7:37 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 06-Jun-18 | Market Purchase | 95,079 | $12.58 | $1,196,370.00 | < 1% 59.3M to 59.39M | (72%) |
| 07-Jun-18 7:37 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 05-Jun-18 | Market Purchase | 173,121 | $12.45 | $2,156,190.00 | < 1% 59.12M to 59.3M | (72%) |